Position in CRBU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,382
+$5,932 QoQ
Shares Held
30,331
+21.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 137 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Derivatives in CRBU
reported options exposure · as of Jun 30, 2026CallValue
$66,704
CallShares
37,900
PutValue
$80,432
PutShares
45,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. CRBU ranks #239 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in CRBU
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,704 | 37,900 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $53,382 | 30,331 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $80,432 | 45,700 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $164,350 | 86,500 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $47,450 | 24,975 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $55,650 | 35,000 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $470,138 | 295,685 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,117,089 | 479,438 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $609,347 | 483,610 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $268,136 | 293,687 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $541,934 | 340,840 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,273,920 | 649,960 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $1,096,339 | 668,500 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $314,665 | 61,219 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $655,127 | 114,333 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $229,846 | 48,085 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $732,338 | 172,315 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $182,652 | 17,313 | Shares | Defined | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||